that the amelioration of hypercholesterolemia has benein cultured murine mesangial cells.
plasminogen activators and plasminogen activator inhibitor-1 (PAI-1), in cultured murine mesangial cells.
Much attention has been directed toward the pathogenic role of cholesterol in glomerular injury and the METHODS relationship between glomerular sclerosis and atheroMurine mesangial cell culture sclerosis. Several studies, including our own, have shown Twenty-four-week-old BALB/c mice were sacrificed, and the kidneys were removed in a sterile manner. Glomerular mesangial cells were cultured according to the Key words: extracellular matrix, platelet-derived growth factor, plasminogen activator inhibitor-1. methods of MacKay et al [6] . Cells obtained from passages 5 to 12 were used for the experiments.
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Simvastatin and mevalonate preparation
Simvastatin salt was kindly provided by Banyu Pharmaceutical Co., Ltd. (Tokyo, Japan) and was prepared as described by Kita et al [7] . Mevalonic acid lactone was prepared as described by O'Donnell et al [8] . Aliquots of these solutions were stored at Ϫ20ЊC until use.
RNA purification and Northern analysis
Preconfluent mesangial cells were cultured in fibronectin-coated 100 mm dishes for 48 hours in serum-free modified Eagle's medium (MEM)/F12 medium (GIBCO BRL, Gaithersburg, MD, USA) to render the cells quiescent and were then further cultured for 24 hours in MEM/ F12 medium with the following additions: 10% fetal calf serum (FCS) only, as a control; 10% FCS and 20 m of simvastatin; and 10% FCS, 20 m of simvastatin, and 100 m of mevalonate. Total RNA of cultured mesangial cells was purified by the acid guanidium thiocyanatephenol-chloroform method, and Northern blot analysis was performed as previously described [9] . Each lane of the autoradiographs was analyzed with BAS-2000 (Fuji film, Tokyo, Japan), and the signal densities of each mRNA, corrected using that of GAPDH, were compared among the conditions mentioned earlier here. The expression of the following mRNA was examined: matrix proteins such as collagen type I (␣1), type III (␣1), type IV (␣1), and fibronectin; growth factors such as PDGF-B chain, PDGF-receptor ␤-subunit (PDGF-R␤), and transforming growth factor-␤ (TGF-␤); and matrix turnover proteins such as matrix metalloproteinase 2 (MMP-2), tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), and PAI-1.
RESULTS
Simvastatin slightly suppressed mRNA expression of collagen IV and fibronectin and slightly up-regulated in contrast to no influence on TGF-␤ mRNA expression. Among the matrix turnover proteins, although MMP-2 and tPA showed no significant changes in gene expresand interleukin-4 [10, 11] . Considering that the in vitro sion, uPA and PAI-1 mRNA expression was significantly synthesis of type I and III collagens was enhanced in reduced by simvastatin. The nearly complete elimination cultured mesangial cells and that of type IV collagen of these effects by the addition of mevalonate indicates was up-regulated in vivo, the signaling pathway affected the direct influence of simvastatin on these parameters by simvastatin for these matrix protein syntheses may ( Fig. 1 in a type-specific manner independent of TGF-␤ and inhibits cell growth in part through the suppressive effects of autocrine PDGF. Moreover, simvastatin suppresses PAI-1 expression with the steady expression of simvastatin, along with complete suppression of DNA synthesis under FCS-stimulated conditions (data not tPA in mesangial cells. Part of the beneficial effects of HMG-CoA reductase inhibitors in renal diseases may be shown), as seen by Grandaliano's group. Considering the difference between these two studies in the condithrough its effect on ECM by enhancing matrix protein degradation. tions that induced up-regulated cell proliferation, simvastatin may inhibit some FCS-induced pathway(s) other by a report of human fibroblasts in which lovastatin has suppressed a signaling response to PDGF less intensely than to epidermal growth factor (EGF) or insulin-like REFERENCES growth factor I (IGF-I) [12] . In addition to the direct tion of tPA but not uPA is dependent on the activity of
